NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.


Journal

Journal of proteome research
ISSN: 1535-3907
Titre abrégé: J Proteome Res
Pays: United States
ID NLM: 101128775

Informations de publication

Date de publication:
05 02 2021
Historique:
pubmed: 12 1 2021
medline: 23 2 2021
entrez: 11 1 2021
Statut: ppublish

Résumé

To investigate the systemic metabolic effects of SARS-CoV-2 infection, we analyzed

Identifiants

pubmed: 33426894
doi: 10.1021/acs.jproteome.0c00876
doi:

Substances chimiques

Chemokines 0
Cytokines 0
Lipoproteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1382-1396

Auteurs

Samantha Lodge (S)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.
Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Western Australia 6150, Australia.

Philipp Nitschke (P)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.

Torben Kimhofer (T)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.
Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Western Australia 6150, Australia.

Jerome D Coudert (JD)

Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.
Perron Institute for Neurological and Translational Science, Nedlands, Western Australia 6009, Australia.
School of Medicine, University of Notre Dame, Fremantle, Western Australia 6160, Australia.

Sofina Begum (S)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.
Section of Nutrition Research , Department of Metabolism, Nutrition and Reproduction, Faculty of Medicine, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, U.K.

Sze-How Bong (SH)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.

Toby Richards (T)

Division of Surgery, Medical School, Faculty of Health and Medical Sciences, University of Western Australia, Harry Perkins Building, Robert Warren Drive, Murdoch, Perth, Western Australia 6150, Australia.

Dale Edgar (D)

Faculty of Health and Medical Sciences, University of Western Australia, Harry Perkins Building, Robert Warren Drive, Murdoch, Perth, Western Australia 6150, Australia.

Edward Raby (E)

Department of Clinical Microbiology, PathWest Laboratory Medicine WA, Murdoch, Perth, Western Australia 6150, Australia.

Manfred Spraul (M)

Biospin GmbH, Silberstreifen, Ettlingen 76275, Germany.

Hartmut Schaefer (H)

Biospin GmbH, Silberstreifen, Ettlingen 76275, Germany.

John C Lindon (JC)

Division of Systems Medicine, Department of Metabolism, Nutrition and Reproduction, Faculty of Medicine, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, U.K.

Ruey Leng Loo (RL)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.
Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Western Australia 6150, Australia.

Elaine Holmes (E)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.
Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Western Australia 6150, Australia.
Section of Nutrition Research , Department of Metabolism, Nutrition and Reproduction, Faculty of Medicine, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, U.K.

Jeremy K Nicholson (JK)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Western Australia 6150, Australia.
Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Western Australia 6150, Australia.
Division of Surgery, Medical School, Faculty of Health and Medical Sciences, University of Western Australia, Harry Perkins Building, Robert Warren Drive, Murdoch, Perth, Western Australia 6150, Australia.
Institute of Global Health Innovation, Imperial College London, Level 1, Faculty Building South Kensington Campus, London SW7 2NA, U.K.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH